Oncogenic transformation induces tumor angiogenesis: A role for PAR1 activation

FASEB Journal

Volumn 17, Issue 2, 2003, Pages 163-174

  Yin, Yong Jun ^a   Salah, Zaidoun ^a   Maoz, Myriam ^a   Ram, Sharona Cohen Even ^a   Ochayon, Shalom ^a   Neufeld, Gera ^b   Katzav, Shulamit ^a   Bar Shavit, Rachel ^a,c  

^a HEBREW UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Invasion; Metastasis; Thrombin receptor; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; TETRACYCLINE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; BLOTTING, NORTHERN; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; GENES, RAS; GENES, SRC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENES; PROTEIN KINASE C; RATS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; RNA, MESSENGER; SRC-FAMILY KINASES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; BOVINAE; VECTORS;

EID: 0037308089     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0316com     Document Type: Article

References (67)

1. Ferrara, N., and Alitalo, K. (1999) Clinical application of angiogenic growth factor and their inhibitors. Nature Med. 5, 1359-1364
2. Hynes, R. O., Bader, B. L., and Hodivala-Dilke, K. (1999) Integrins in vascular development. Braz. J. Med. Biol. Res. 32, 501-510
3. Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature (London) 407, 249-257
4. Folkman,J. (1971) Tumor angiogenic therapoeitic implications. N. Engl. J. Med. 285, 1182-1186
5. Hanahan, D., and Folkman, J. (1996) Pattern and emerging mechanisms of angiogenic switch during tumorigenesis. Cell 86, 353-364
6. Trousscau, A. (1872) Lectures in Clinical Medicine Delivered in Hotel-Dieu, Paris pp. 281-295, New Sydenham Society, London
7. Rickles, F. R., and Edwards, R. L. (1983) Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62, 14-31
8. Sloane, B. F., Rozhin, J., Johnson, K., Taylor, H., Crissman, J. D., and Honn, K. Y. (1986) Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA 83, 2483-2487
9. Zacharski, L. R., Memoli, V. A., Morian, W. D., Schlaeppi, J. M., and Roussceu, S. M. (1995) Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Throm. Haemostasis 73, 793-797
10. Even-Ram, S., Uziely, B., Cohen, P., Ginzburg, Y., Reich, R. Vlodavsky, I., and Bar-Shavit, R. (1998) Thrombin receptor overexpression in physiological and malignant invasion process. Nature Med. 4, 909-914
11. Even-Ram, C. S., Maoz, M., Pokroy, E., Reich, R., Katz, B.-Z., Gutwein, P., Altevogt, P., and Bar-Shavit, R. (2001) Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with αvβ5 integrin. J Biol. Chem. 276, 10952-10962
12. Vu, T.-K., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068
13. +2 mobilization. FEBS Lett. 288, 123-128
14. Martin, C. B., Mahon, G. M., Klinger, M. B., Kay, R. J., Symons, M., Der, C. J., and Whitehead, I. P. (2001) The thrombin receptor. PAR-1 causes transformation by activation of Rhomediated signaling pathways. Oncogene 20, 1953-1963
15. Connolly, A. J., Ishihara, H., Kahn, M. L., Fares, Jr., R. V., and Coughlin, S. R. (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature (London) 381, 516-519
16. Bugge, T. H., Xiao, Q., Kombrinck, K. W., Flick, M. J., Holmback, K., Danton, M.J., Colbert, M. C., Witte, D. P., Fujikawa, K., Davie, E. W., and Degen, J. L. (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc. Natl. Acad. Sci. USA 93, 6258-6263
17. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (London) 380, 435-439
18. Toomey, J. R., Kratzer, K. E., Lasky, N. M., Stanton, J. J., and Broze, Jr., G.J. (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88, 1583-1587
19. Cui,J., O'Shea, K. S. M., Purkayastha, A., Saunders, T. L., and Ginsburg, D. (1996) Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature (London) 384, 66-68
20. Sun, W. Y., Witte, D. P., Degen, J. L., Colbert, M. C., Burkart, M. C., Holmback, K., Xiao, Q., Bugge, T. H., and Degen, S. J. (1998) Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc. Natl. Acad. Sci. USA. 95, 7597-7602
21. Xue, J., Wu, Q., Westfield, L. A., Tuley, E. A., Lu, D., Zhang, Q., Shim, K., Zheng, X., and Sadler, J. E. (1998) Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc. Natl. Acad. Sci. USA 95, 7603-7607
22. Griffin, C. T., Snirivasan, Y., Zheng, Y.-W., Haung, W., and Coughlin, S. R. (2001) A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293, 1666-1670
23. Preissner, K. T., Nawroth, P. P., and Kanse, S. M. (2000) Vascular protease receptors: integrating haemostasis and endothelial cell functions. J. Pathol. 190, 360-372
24. Carmeliet, P. (2001) Clotting factors build blood vessels. Science 293, 1602-1604
25. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524
26. Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-1683
27. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22
28. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (London) 362, 841-844
29. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (London) 367, 576-579
30. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (London) 380, 435-439
31. Shalaby, F., Ho, J., Stanford, W. L., Fischer, K. D., Schuh, A. C., Schwartz, L., Bernstein, A., and Rossant, J. (1997) A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89, 981-990
32. Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995) Role of Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (London) 376, 66-70
33. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359, 843-845
34. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. (1992) Vascular endothelial growth factor is a potent tumor angiogenesis factor in human gliomas in vivo. Nature (London) 359, 845-848
35. Leung, D. W., Cachianes, G., Kuang, W. J., Goddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
36. Tischer, E., Gospadorowicz, D., Mitchell, R., Silva, M., Schilling, J., Lau, K., Crisp, T., Fiddes, J. C., and Abraham, J. A. (1989) Vascular endothelial growth factor: a new member of the platelet-derived growth gene family. Bichem. Biophys. Res. Commun. 165, 1198-1206
37. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165
38. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312
39. Houck, K. A., Ferrara, N., Winer, J., Cachiaes, G., Li, B., and Leung, D. W. (1991) The vascular endothelial growth factor family-identification of a fourth molecular species and characterization of a alternative splicing RNA. Mol. Endocrinol. 5, 1806-1814
40. Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B., and Neufeld, G. (1995) VEGF121, a vascular endothelial growth factor isoform lacking heparin binding ability, requires cell surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 270, 11322-11326
41. Park, J. E., Keller, G. A., and Ferrara, N. (1993) Vascular endothelial growth factor (VEGF) isoforms-differential deposition into the subepithelial eextracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326
42. Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., and Neufeld, G. (1997) VEGF 145: a secreted VEGF form that binds to extracellular matrix. J. Biol. Chem. 272, 7151-7158
43. Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N., Stockschlader, M., and Hossfeld, D. K. (1997) Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 89, 1870-1875
44. Schnaper, H. W., Grant, D. S., Stetler-Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoytha, M., Fuerst, T. R., French, D. L., Quigley, J. P., and Klienman, H. K. (1993) type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156, 235-246
45. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grants, D. S., and Martin, G. R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528
46. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051
47. Miao, H.-Q., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. (2000) Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14, 2532-2539
48. Chen, Y.-H., Pouyssegur, J., Coutridge, S. A., and Van Obberghen-Schilling, E. (1994) Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J. Biol. Chem. 269, 27372-27377
49. Shock, D. D., He, K., Wencel-Drake, J. D., and Parise, L. V. (1997) Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or prote. Biochem. J. 321, 525-530
50. Ellis, C. A., Malik, A. B., Gilchrist, A., Hamm, H., Sandoval, R., Voyno-Yasenetskaya, T., and Tiruppathi, C. (1999) Thrombin induces proteinase-activated receptor-1 gene expression in endothelialcells via activation of Gi-linked Ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 274, 13718-13727
51. Cichowski, K., Brugge, J. S., and Brass, L. F. (1996) Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets. J. Biol. Chem. 271, 7544-7550
52. Bar-Shavit, R., Maoz, M., Yongjun, Y., Groysman, M., Dekel, I., and Katzav, S. (2002) Signalling pathways induced by protease-activated receptors and integrins in T cells. Immunology 105, 35-46
53. Tsopanoglou, N. E., and Maragoudakis, M. E. (1999) On the mechanism of thrombin-induced angiogenesis. J. Biol. Chem. 274, 23969-23976
54. Richard, D. E., Vouret-Craviari, V., and Pouyssegur, J. (2001) Angiogenesis and G-protein coupled receptors: signals and bridge the gap. Oncogene 20, 1556-1562
55. Huang, Y.-Q., Li, J.-J., Hu, L., Lee, M., and Karpatkin, S. (2001) Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts. DU 145 prostate cells and CHRF megakaryocytes. Throm. Haemst. 86, 1094-1098
56. Carter, A. N., Haung, R., Sorisk, A., Downes, C. P., and Rittenhouse, S. E. (1994) Phosphatidylinositol 3,4,5-triphosphate is formed from phosphatidylinositol 4,5-bis-phosphate in thrombin-stimulated platelets. Biochem. J. 310, 415-420
57. Gutkind, J. S., Lacal, P. M., and Robbins, K. C. (1990) Thrombin-dependent association of phosphatidylinositol-3-kinase with p60c-src and p59fyn in human platelets. Mol. Cell. Biol. 10, 3806-3809
58. Leach, K., L., Ruff, V. A., Jarpe, M. B., Adams, L. D., Fabbro, D., and Raben, D. M. (1992) Alpha thrombin stimulates nuclear localization of protein kinse C isozyme in IIC9 cells. J. Biol. Chem. 267, 21816-21822
59. Chen, Y., Grall, D., Salcini, A. E., Pelicci, P. G., Pouyssegur, J., and Van Obberghen-Schilling, E. (1996) Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J. 15, 1037-1044
60. Collins, L. R., Rickets, W. A., Olefsky, J. M., and Brown, J. H. (1997) The G12 coupled thrombin receptor stimulates mitogenesis through the Shc SH2 domain. Oncogene 15, 595-600
61. Maulon, L., Mari, B., Bertolotto, C., Ricci, J. E., Luciano, F., Belhacene, N., Deckert, M., Baier, G., and Auberger, P. (2001) Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKC epsilon. Oncogene 20, 1964-1972
62. Ricketts, W.A., Brown, J. H., and Olefsky, J. M. (1999) Pertussis toxin-sensitive and -insensitive thrombin stimulation of Shc phosphorylation and mitogenesis are mediated through distinct pathways. Mol. Endocrinol. 13, 1988-2001
63. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. (1995) Endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25915-25919
64. Meadows, K. N., Bryant, P., and Pumiglia, K. (2001) Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J. Biol. Chem. 276, 49289-49298
65. Landau, E., Tirosh, R., Pinson, A., Banai, S., Even-Ram, S., Maoz, M., Katzav, S., and Bar-Shavit, R. (2000) Protection of thrombin receptor expression under hypoxia. J. Biol. Chem. 275, 2281-2287
66. Katzav, S. (1993) Single point mutation in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav. Oncogene 8, 1757-1763
67. Katzav, S., Packham, G., Sutherland, M., Aroca, P., Santos, E., and Cleavland, J. L. (1995) Vav and ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene 11, 1079-1088